SCHEMBL22255684

SCHEMBL22255684

c1ccc(-c2cc3ccccc3cc2-c2ccc(N(c3ccc(-c4cc5ccccc5c5ccccc45)cc3)c3cccc4sc5ccccc5c34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
MPI P34949 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GPR84 Q9NQS5 2/20 0.32
PTGS2 P35354 1/20 0.32
F9 P00740 1/20 0.32
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23258158 0.96 CYP11B1 (0.35) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23258752 0.96 CYP11B1 (0.35) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23258075 0.96 CYP11B1 (0.35) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23258051 0.95 ALDH1A1 (0.35) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23258753 0.95 ALDH1A1 (0.36) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23822486 0.94 CYP11B1 (0.33) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL22255342 0.94 HSD17B1 (0.33) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23258751 0.94 CYP11B1 (0.34) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL22452167 0.94 PTGS2 (0.34) ALDH1A1HPGDKDM4EMEN1MAPT
SCHEMBL22255685 0.94 PTGS2 (0.34) ALDH1A1HPGDKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235297-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235297-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA CYP11B1 443/4885ALDH1A1 89/4885HPGD 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.